Advertisement
Screener

MOSAIC IMMUNOENGINEERING, INC. (CPMV) Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate

1.6 / 5 stars · 18/57 Roast Me

MOSAIC IMMUNOENGINEERING, INC. Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate

MOSAIC IMMUNOENGINEERING, INC. (CPMV) reported Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate of 4.42% for the 12-month period ending 2022-12-31, per its 10-K filed 2023-03-02.

Discontinued › Notes › Compensation Related Costs › Share-Based Payment Arrangement, Disclosure › Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions and Methodology

us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate · last filed 2023-03-02

  • MOSAIC IMMUNOENGINEERING, INC. share-based compensation arrangement by share-based payment award, fair value assumptions, risk free interest rate for the quarter ending 2022-03-31 was 1.06%, a 3433.33% increase year-over-year.
  • MOSAIC IMMUNOENGINEERING, INC. share-based compensation arrangement by share-based payment award, fair value assumptions, risk free interest rate for the quarter ending 2021-03-31 was 0.03%.
  • MOSAIC IMMUNOENGINEERING, INC. share-based compensation arrangement by share-based payment award, fair value assumptions, risk free interest rate for the quarter ending 2020-08-21 was 0.11%.
  • MOSAIC IMMUNOENGINEERING, INC. share-based compensation arrangement by share-based payment award, fair value assumptions, risk free interest rate for the quarter ending 2015-02-28 was 0.00%.
  • MOSAIC IMMUNOENGINEERING, INC. share-based compensation arrangement by share-based payment award, fair value assumptions, risk free interest rate for fiscal 2022 was 4.42%, a 7266.67% increase from fiscal 2021.
  • MOSAIC IMMUNOENGINEERING, INC. share-based compensation arrangement by share-based payment award, fair value assumptions, risk free interest rate for fiscal 2021 was 0.06%.
  • MOSAIC IMMUNOENGINEERING, INC. share-based compensation arrangement by share-based payment award, fair value assumptions, risk free interest rate for fiscal 2015 was 1.51%, a 43.81% increase from fiscal 2014.
  • MOSAIC IMMUNOENGINEERING, INC. share-based compensation arrangement by share-based payment award, fair value assumptions, risk free interest rate for fiscal 2014 was 1.05%.
Period endShare-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate 3 monthShare-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate 6 monthShare-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate 7 monthShare-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate 9 monthShare-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate 12 month
2022-12-314.42%
10-K · filed 2023-03-02
2022-09-303.92%
10-Q · filed 2022-11-01
2022-06-302.51%
10-Q · filed 2022-08-04
2022-03-311.06%
10-Q · filed 2022-05-10
2021-12-310.06%
10-K · filed 2023-03-02
2021-09-300.05%
10-Q · filed 2021-11-02
2021-06-300.05%
10-Q · filed 2021-08-03
2021-03-310.03%
10-Q · filed 2021-05-05
2020-12-310.09%
10-K · filed 2022-01-26
2020-08-210.11%
10-K · filed 2022-01-26
2015-05-311.51%
10-K · filed 2016-08-29
2015-02-280.00%
10-Q · filed 2015-04-14
0.00%
10-Q · filed 2015-04-14
2014-11-300.00%
10-Q · filed 2015-01-14
2014-08-310.00%
10-Q · filed 2014-10-15
2014-05-311.05%
10-K · filed 2015-08-31
2014-02-280.00%
10-Q · filed 2015-04-14
1.05%
10-Q · filed 2015-04-14
2013-11-301.05%
10-Q · filed 2015-01-14
2013-08-311.05%
10-Q · filed 2014-10-15